Skip to search.
 TSX Down0.27% TSX Ventures 0.00%

Novo Nordisk A/S (NVO)

-NYSE

167.99 Down 0.93(0.55%) 9:49AM EDT - Nasdaq Real Time Price

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.0
Mean Recommendation (last week):1.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:199.15
Median Target:199.15
High Target:199.15
Low Target:199.15
No. of Brokers:1

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
2010-03-30Deutsche BankInitiated Hold
2010-03-29Mehta PartnersDowngradeOutperformMarket Perform
2010-02-23Jefferies & CoUpgradeHoldBuy
2010-01-14Jefferies & CoDowngradeBuyHold
2009-09-10Jefferies & CoInitiated Buy
2009-08-06JP MorganDowngradeOverweightNeutral
2009-08-06UBSDowngradeBuyNeutral
2009-05-11Piper JaffrayInitiated Buy
2009-04-23CitigroupUpgradeHoldBuy
2009-03-25UBSUpgradeNeutralBuy
Data provided by Briefing.com

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.